Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.
Am J Addict March 1, 2026 DOI: 10.1111/ajad.70128 (opens in new tab) via PubMed
Summary
AI-generated from the abstractThe text discusses the tension between the urgent need for effective treatments for substance use disorders and the uncertainty surrounding the efficacy and safety of psychedelic-assisted therapy. It highlights the potential benefits of using psychedelics in therapeutic settings while emphasizing the lack of conclusive evidence and the need for rigorous research to address gaps in knowledge. The authors call for a balanced approach that acknowledges both the promise and the risks, urging careful consideration of ethical, clinical, and regulatory challenges before widespread implementation.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key finding | Argues that the field of psychedelic-assisted therapy for substance use disorders must balance therapeutic promise with scientific rigor to avoid premature implementation that could compromise patient safety and credibility. |
Abstract
Psychedelic-assisted therapy for substance use disorders: Between urgency and uncertainty.